Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
Cochrane Database Syst Rev. 2018 Jul 05;7:CD010885
Authors: van As JW, van den Berg H, van Dalen EC
Abstract BACKGROUND: Platinum-based therapy, including cisplatin, carboplatin or oxaliplatin, or a combination of these, is used to treat a variety of paediatric malignancies. Unfortunately, one of the most important adverse effects is the occurrence of hearing loss or ototoxicity.